12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women

PURPOSE: Define the effectiveness of teriparatide (TPTD) treatment on reducing the incidence of new vertebral compression fractures (NVCFs) and back pain and improving quality of life after percutaneous kyphoplasty (PKP). METHODS: Two years of clinical follow-up data from primary osteoporotic women...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Meng, Zhou, Chuanli, Zhu, Kai, Zhang, Yiran, Song, Mengxiong, Zhang, Hao, Tu, Qihao, Ma, Xuexiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778479/
https://www.ncbi.nlm.nih.gov/pubmed/31631990
http://dx.doi.org/10.2147/CIA.S224663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778479/
https://www.ncbi.nlm.nih.gov/pubmed/31631990
http://dx.doi.org/10.2147/CIA.S224663

Ejemplares similares